The Best Fintech Stocks to Buy With $500 Right Now

Affirm reported 25.8M active consumers (vs 21M a year earlier), 6.4 average transactions (vs 5.3) and 478k active merchants (vs 337k); analysts expect fiscal 2025–2028 revenue and adjusted EBITDA CAGRs of 26% and 132%, and the company trades at an enterprise value of ~$18B (~16x this year's adjusted EBITDA). Chime served 9.5M active members at end-2025 (+19% YoY); analysts project 2025–2028 revenue and adjusted EBITDA CAGRs of 19% and 92%, and it trades at an enterprise value of ~$7.6B (~19x this year's adjusted EBITDA). Both companies are positioned to capture younger and lower-income customers as fintech adoption rises, supporting a constructive long-term outlook.

Analysis

Winners will be platforms that own both the checkout flow and the credit underwriting; losers will be incumbent card issuers and commodity acquirers unless they either replicate embedded financing or materially lower merchant economics. A 5–10 percentage-point shift of transactional volume away from legacy credit rails over 2–4 years would reallocate billions in swipe revenue into platform economics (interchange splits, merchant financing fees, and repeat-purchase arbitrage), magnifying value for firms that can monetize repeat usage and data.

Key second-order fragilities: bank partners that sponsor deposits and issue rails (the thin-margin custodial banks) see concentration risk — a rapid re-pricing of incentives from fintech partners or a funding shock at a sponsor bank could force product rollback within quarters. Credit performance is the other hinge; underwriting improvements (AI-driven decisioning) can compress losses, but adverse macro shocks or model breakdowns in stressed cohorts will surface as deteriorating loss curves within 2–6 quarters.

Catalysts to watch: merchant contract churn and net take-rate pressure (quarterly), regulatory guidance on point-of-sale financing (6–18 months), and unemployment/consumer credit trends (6–24 months). The consensus is bullish on secular adoption but underprices operational concentration (sponsor bank and interchange dependency) and regulatory vector risk — that makes structured, convex exposures preferable to outright carry positions.

Key Decisions for Investors

• Long AFRM via a 12–18 month call spread (buy 1y ATM call / sell 1y OTM call) sized 1–2% portfolio; enter on post-earnings IV compression or a pullback >10% from the prior session. R/R: capped upside ~2–3x premium if adoption/merchant take-rates accelerate; downside limited to premium (use a stop if implied vol jumps >40% post-event).
• Pair trade: long CHYM equity (or 9–12 month LEAP calls) + short regional-bank ETF KRE (equal notional) to isolate fintech share gains vs bank fee erosion. Timeframe 6–18 months; target 30–50% relative outperformance, stop if CHYM underperforms by >25% and KRE rallies >15% on rate-news.
• Long-short credit-issuer hedge: long AFRM (or calls) vs short COF or SYF via 6–12 month put spreads on the issuer. Rationale: capture margin shift from card interest/swipe to platform financing; aim for 2:1 potential upside vs downside cost, reduce macro beta.
• Event hedge: buy inexpensive 6–12 month OTM puts on AFRM/CHYM ahead of major regulatory windows (CFPB or Congressional hearings) sized to limit max loss to 0.5% portfolio. This preserves upside participation while capping tail regulatory risk.